Metastatic Platinum-Resistant Ovarian Carcinoma
1 clinical trials · Condition
◉ Watch Metastatic Platinum-Resistant Ovarian Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers (NCT05691504) | National Cancer Institute (NCI) | 2023-09-14 |
Track Metastatic Platinum-Resistant Ovarian Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.